1472104-38-3

Upstream product

• 1181458-21-8 (4-Bromo-2-methoxy-6-methyl-phenyl)-amine hydrobromide 
• 877149-05-8 4-bromo-2-methoxy-6-methyl-benzonitrile 
• 1244949-43-6 4-bromo-2-methoxy-6-methyl-benzaldehyde 
• 877149-08-1 4-bromo-2-methoxy-6-methyl-benzoic acid 
• 75-03-6 ethyl iodide 
• 50868-73-0 2-methoxy-6-methylbenzeneamine 

Downstream Products

• 1472104-39-4 2-methoxy-6-methyl-4-morpholin-4-yl-benzoic acid ethyl ester 
• 1472103-93-7 2-cyclopropyl-N-[(3R)-3-hydroxy-4,4-dimethyl-pentyl]-6-methyl-4-morpholin-4-yl-benzamide 
• 1472104-42-9 2-cyclopropyl-6-methyl-4-morpholin-4-yl-benzoic acid 
• 1472104-41-8 2-cyclopropyl-6-methyl-4-morpholin-4-yl-benzoic acid ethyl ester 
• 1472104-40-7 2-methyl-4-morpholin-4-yl-6-(trifluoromethylsulfonyl)oxy-benzoic acid ethyl ester 
• 65219-95-6 2-hydroxy-6-methyl-4-morpholin-4-yl-benzoic acid ethyl ester 

Relevant academic research and scientific papers

Isoindoline, azaisoindoline, dihydroindenone and dihydroazaindenone inhibitors of Mnk1 and Mnk2

The present invention provides synthesis, pharmaceutically acceptable formulations and uses of compounds in accordance with Formula I, or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof. For Formula I compounds A1, A2

SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS

The invention relates to substituted 4-aminobenzamides, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.

SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS

Substituted 4-aminobenzamides, pharmaceutical compositions containing these compounds and also methods of using these compounds in the treatment and/or prophylaxis of pain and further diseases and/or disorders.